About Pragya Pandey
Pragya is an equity research analyst and financial journalist with a passion for investing. In college she majored in finance and is currently pursuing the CFA program and is a Level II candidate.
When analyzing stocks, Pragya takes a fundamental approach and focuses on measuring a company's intrinsic value. Her goal is to help retail investors create successful portfolios to achieve financial success.
Recent Articles By Pragya Pandey
Is Unilever a Good Stock to Add to Your Dividend Portfolio?
Global consumer goods giant Unilever (UL) has attained a solid market position based on its robust operational performance over the past years. In addition, the company has an impressive dividend payout history and expects double-digit growth in the coming year as the market recovers from pandemic disruptions. So, is the stock worth betting on now? Read on to learn our view.
Grab These 2 Stocks Under $10 Rated 'Strong Buy' in the POWR Ratings
Although the major stock indexes hit record highs this week, rising inflation could perplex investors in the coming weeks. So, we think the stocks of VAALCO Energy (EGY) and Blueknight Energy (BKEP), which are currently trading at less than $10, could be great picks now. They are rated "Strong Buy" in our proprietary ratings system, and we think hold significant upside potential owing to their impressive fundamentals and solid growth attributes. Read on to learn more.
2 WallStreetBets Stocks Worth Owning in 2022
Some of the names discussed on the subreddit WallStreetBets continue to grab Wall Street’s attention owing to their solid growth attributes. Microsoft Corporation (MSFT) and Pfizer (PFE) have witnessed significant price rallies over the past few months and should deliver substantial returns in the near term. So, they could be ideal picks now. Read on.
Despite its High Valuation, is Lattice Semiconductor a Buy?
Lattice Semiconductor's (LSCC) shares have soared 70.5% year-to-date based on its robust financial performance over the past year. Although the stock is currently trading at a premium valuation, is it worth buying it now, considering its solid growth attributes? Let's find out.
Is Cintas Stock a Good 'Buy the Dip' Candidate?
Cintas (CTAS) has garnered significant investor attention lately on its impressive operational performance in its last reported quarter. However, worries related to the new COVID-19 variant caused the company to deliver disappointing fiscal 2022 guidance, causing its stock to retreat nearly 2% in price last week. So, is it worth betting on the stock at the current price level? Let's find out. `
2 Small-Cap Travel Stocks to Scoop Up for a Rebound in 2022
The travel industry was well on its path to recovery, but the omicron variant has again marred its growth. However, the efficacy of existing vaccines and other therapies and easing travel restrictions should bolster the travel industry's growth in 2022. So, we believe it is an opportune time to bet on fundamentally sound, small-cap travel stocks Trivago (TRVG) and Travelzoo (TZOO). Read on.
After Announcing 63 Store Closures, is Rite Aid Stock a Buy?
Healthcare company Rite Aid's (RAD) shares have surged 7.5% in price over the past month. However, given the company's negative profit margins and its plans to shut 63 stores in the coming weeks, will the stock be able to maintain its momentum in the near term? Read more to learn our view.
Is FactSet Research Systems Stock a Buy, Sell, or Hold?
The stock of global analytics and data solutions provider FactSet Research (FDS) has outperformed the broader market year-to-date because investors remain bullish on its growth prospects. So, given the company’s continuing efforts to boost its operational performance and its solid fundamentals, is it worth betting on the stock now? Let's find out.
Is Teladoc Health a Buy Under $100?
Shares of virtual healthcare operator Teladoc Health (TDOC) have plummeted due to the company’s underwhelming third-quarter earnings and are currently trading at less than $100. Although the company’s personalized virtual care solutions should benefit the stock, its high valuation and expanding losses in the face of rising competition could be concerning. So, is it worth adding the stock to one’s portfolio now? Read on to learn more.